Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
Vienna, Austria, April 28, 2026 (GLOBE NEWSWIRE) -- Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing...
Faex Health Announces Investigational AI Screening Capabilities for Ebola and H. pylori, Expanding Gut Health Platform to 18 Conditions